Comparing the current results to its competitors, United Health Products Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 5.72 %, recorded in the same quarter.
United Health Products Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 3.13 %
United Health Products Inc 's Comment on Competition and Industry Peers
The Class III human surgical market has limited competitors offering Class III approved hemostatic agents, enabling premium pricing. The company aims to compete in this market with its CelluSTAT technology, subject to FDA pre-market approval. The U.S. wound care products market is dominated by large, established companies with substantial capital and operational resources. The company's hemostatic gauze product will compete directly with products from Baxter International, Becton Dickinson & Company, Johnson & Johnson (Ethicon), Teleflex, and 3M Company. Key competitive factors include product performance, price, product range, value-added service programs, service and delivery, credit terms, and customer support.
November 4, 2024
Mount Laurel, N.J. On November 4, 2024, United Health Products, Inc. (OTCPK: UEEC) issued a formal update concerning its ongoing Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA). The company, recognized for its innovations in the healthcare sector, particularly in wound management, has been navigating this crucial regulatory pathway to bring new advancements to medical professionals and patients alike.The PMA process, which is required for class III medical devices, represents a rigorous scientific and regulatory assessment conducted by the FDA. It ensures that products meet high standards of safety and efficacy before being approved for market entry. The company s curr...
Plus Therapeutics Inc is a biotechnology company that focuses on developing precision nanoparticles for targeted therapy. They utilize their proprietary technology to create and commercialize innovative drugs for the treatment of cancer and other diseases.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Mediwound Ltd operates through the development, manufacturing, and commercialization of biopharmaceutical products. Their business model primarily involves leveraging their expertise in biotechnology to create innovative therapies for the treatment of severe burns, chronic wounds, and other healing disorders.
3M Company operates a diversified business model by offering innovative solutions across multiple segments, including healthcare, safety and industrial, transportation, and consumer goods. The company leverages its extensive portfolio of patents and deep customer relationships to drive product development and market responsiveness, focusing on delivering value across various industries.
Sources:
United Health Products Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on United Health Products Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
